Effect of eptifibatide, a glycoprotein IIb/IIIa antagonist, among diabetic patients following coronary stenting: Results from ESPRIT

被引:0
|
作者
Labinaz, M
Madan, M
McGuire, DK
Batchelor, W
Saucedo, J
Pacchiana, C
Kitt, MM
O'Shea, JC
Talley, DJ
Liu, H
Timmis, S
Tcheng, JE
机构
[1] Univ Ottawa, Inst Heart, Ottawa, ON, Canada
[2] Sunnybrook Hosp, Toronto, ON, Canada
[3] Duke Univ, Durham, NC USA
[4] Univ Toronto, Toronto, ON, Canada
[5] Univ Arkansas, Med Ctr, Little Rock, AR 72204 USA
[6] Duke Clin Res Inst, Durham, NC USA
[7] Cor Therapeut, San Francisco, CA USA
[8] Univ Arkansas, Little Rock, AR 72204 USA
[9] Jackson Madison Hosp, Jackson, TN USA
[10] William Beaumont Hosp, Royal Oak, MI 48072 USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
3215
引用
收藏
页码:665 / +
页数:2
相关论文
共 50 条
  • [31] Glycoprotein IIb/IIIa receptor antagonism in patients with acute coronary syndromes and prior coronary artery bypass grafting: Results from PRISM PLUS
    Servoss, SJ
    Wan, Y
    Snapinn, SM
    DiBattiste, PM
    Theroux, P
    Jang, IK
    Januzzi, JL
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (06) : 364A - 364A
  • [32] Coronary stenting in diabetic patients: Results from the ROSETTA registry
    Huynh, T
    Eisenberg, M
    Deligonul, U
    Tsang, J
    Okrainec, K
    Schechter, D
    Lefkovits, J
    Mak, KH
    Brown, DL
    Brieger, D
    AMERICAN HEART JOURNAL, 2001, 142 (06) : 960 - 964
  • [33] Effect of clopidogrel loading before percutaneous coronary intervention in patients treated with glycoprotein IIb/IIIa inhibitors
    Assali, A
    Sdringola, S
    Salloum, J
    Moustapha, A
    Ghani, M
    Schroth, G
    Anderson, HV
    Smalling, RW
    Rosales, O
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (02) : 83A - 83A
  • [34] Meta-analysis of glycoprotein IIb/IIIa inhibition in primary percutaneous coronary intervention among unselected patients
    Kouz, R.
    Kouz, S.
    Schampaert, E.
    Rinfret, S.
    Eisenberg, M.
    Lauzon, C.
    Nguyen, M.
    Harvey, R.
    Huynh, T.
    CANADIAN JOURNAL OF CARDIOLOGY, 2007, 23 : 58C - 58C
  • [35] Stenting and glycoprotein IIb/IIIa inhibition in patients with acute myocardial infarction undergoing percutaneous coronary intervention: Findings from the Global Registry of Acute Coronary Events (GRACE)
    Montalescot, G
    Van de Werf, F
    Gulba, DC
    Avezum, A
    Brieger, D
    Kennelly, BM
    Mazurek, T
    Spencer, F
    White, K
    Gore, JM
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2003, 60 (03) : 360 - 367
  • [36] Economic evaluation of bivalirudin with provisional glycoprotein IIb/IIIa inhibition versus heparin with routine glycoprotein IIb/IIIa inhibition for percutaneous coronary intervention - Results from the REPLACE-2 trial
    Cohen, DJ
    Lincoff, AM
    Lavelle, TA
    Chen, HL
    Bakhai, A
    Berezin, RH
    Jackman, D
    Sarembock, IJ
    Topol, EJ
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 44 (09) : 1792 - 1800
  • [37] Glycoprotein IIb-IIIa Antagonist Monafram in Primary Angioplasty of Patients With Acute Coronary Syndrome Without ST Segment Elevation
    Pevzner, D. V.
    Staroverov, I. I.
    Samko, A. M.
    Frolova, N. S.
    Mazurov, A. V.
    Ruda, M. Ya.
    KARDIOLOGIYA, 2010, 50 (06) : 22 - 26
  • [38] The influence of the platelet PIA2 polymorphism on the response to a glycoprotein IIb/IIIa antagonist in patients with acute coronary syndromes.
    O'Connor, F
    Molloy, MA
    Shields, DC
    Fitzgerald, DJ
    BLOOD, 1999, 94 (10) : 244A - 244A
  • [39] Level of inhibition of platelet aggregation predicts outcome of patients treated with the oral glycoprotein IIb/IIIa receptor antagonist lefradafiban: Results from FROST
    Akkerhuis, M
    Roth, U
    Hoffmann, J
    Brickl, R
    Simoons, ML
    CIRCULATION, 2000, 102 (18) : 377 - 377
  • [40] Evaluation of the oral glycoprotein IIb/IIIa antagonist Ro 48-3657 in patients past acute coronary syndromes: Primary results of the TIMI 12 trial
    Cannon, CP
    Novotny, WF
    McCabe, CH
    Tischler, MD
    Borzak, S
    Henry, TD
    Feldman, R
    Hamilton, S
    Rothman, JM
    Braunwald, E
    CIRCULATION, 1996, 94 (08) : 3231 - 3231